These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 3319135

  • 1. Pharmacokinetics of carboplatin after i.v. administration.
    Elferink F, van der Vijgh WJ, Klein I, Vermorken JB, Gall HE, Pinedo HM.
    Cancer Treat Rep; 1987 Dec; 71(12):1231-7. PubMed ID: 3319135
    [Abstract] [Full Text] [Related]

  • 2. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI, Boxall FE, Goddard PM, Valenti M, Jones M, Murrer BA, Abrams M, Kelland LR.
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [Abstract] [Full Text] [Related]

  • 3. Comparative pharmacokinetics of cisplatin and three analogues in mice and humans.
    van Hennik MB, van der Vijgh WJ, Klein I, Elferink F, Vermorken JB, Winograd B, Pinedo HM.
    Cancer Res; 1987 Dec 01; 47(23):6297-301. PubMed ID: 3315183
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of satraplatin (JM216), an oral platinum (IV) complex under daily oral administration for 5 or 14 days.
    Vouillamoz-Lorenz S, Buclin T, Lejeune F, Bauer J, Leyvraz S, Decosterd LA.
    Anticancer Res; 2003 Dec 01; 23(3C):2757-65. PubMed ID: 12926110
    [Abstract] [Full Text] [Related]

  • 5. [The pharmacokinetics of intraperitoneal (IP) carboplatin (CBDCA) and dose-up study of intravenous (IV) cyclophosphamide (CPM) in combination with IP CBCDA for advanced ovarian cancer patients].
    Fujiwara K, Yamauchi H, Sawada S, Koike H, Mohri H, Ohishi Y, Kohno I.
    Gan To Kagaku Ryoho; 1992 Dec 01; 19(14):2373-9. PubMed ID: 1463344
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetic study of intralesional cisplatin for the treatment of hepatocellular carcinoma.
    Mok TS, Kanekal S, Lin XR, Leung TW, Chan AT, Yeo W, Yu S, Chak K, Leavitt R, Johnson P.
    Cancer; 2001 Jun 15; 91(12):2369-77. PubMed ID: 11413527
    [Abstract] [Full Text] [Related]

  • 7. [Pharmacokinetics of carboplatin in a patient under hemodialysis].
    Kurata H, Yoshiya N, Ikarashi H, Kaneko T, Kodama S, Tanaka K, Suzuki K, Yoshizawa H, Cho T, Suzuki E.
    Gan To Kagaku Ryoho; 1994 Mar 15; 21(4):547-50. PubMed ID: 8129398
    [Abstract] [Full Text] [Related]

  • 8. A Phase I and pharmacological study of the platinum polymer AP5280 given as an intravenous infusion once every 3 weeks in patients with solid tumors.
    Rademaker-Lakhai JM, Terret C, Howell SB, Baud CM, De Boer RF, Pluim D, Beijnen JH, Schellens JH, Droz JP.
    Clin Cancer Res; 2004 May 15; 10(10):3386-95. PubMed ID: 15161693
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics and tissue distribution of novel traditional Chinese medicine-platinum anticancer agents in rats.
    Wang X, Au-Yeung SC, Ho YP.
    J Inorg Biochem; 2007 Jun 15; 101(6):909-17. PubMed ID: 17428541
    [Abstract] [Full Text] [Related]

  • 10. Plasma and cerebrospinal fluid pharmacokinetics of intravenous oxaliplatin, cisplatin, and carboplatin in nonhuman primates.
    Jacobs SS, Fox E, Dennie C, Morgan LB, McCully CL, Balis FM.
    Clin Cancer Res; 2005 Feb 15; 11(4):1669-74. PubMed ID: 15746072
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of carboplatin at a dose of 750 mg m-2 divided over three consecutive days.
    Mulder PO, de Vries EG, Uges DR, Scaf AH, Sleijfer DT, Mulder NH.
    Br J Cancer; 1990 Mar 15; 61(3):460-4. PubMed ID: 2183874
    [Abstract] [Full Text] [Related]

  • 12. Cisplatin administered as a continuous 5-day infusion: plasma platinum levels and urine platinum excretion.
    Belliveau JF, Posner MR, Ferrari L, Crabtree GW, Cummings FJ, Wiemann MC, O'Leary GP, Griffin H, Phaneuf MA, O'Rourke A.
    Cancer Treat Rep; 1986 Oct 15; 70(10):1215-7. PubMed ID: 3756943
    [Abstract] [Full Text] [Related]

  • 13. [Pharmacokinetics study of intraperitoneal cisplatin in ovarian carcinoma].
    Han GR, Cai GF.
    Zhonghua Fu Chan Ke Za Zhi; 1993 Apr 15; 28(4):224-6, 254. PubMed ID: 8404307
    [Abstract] [Full Text] [Related]

  • 14. Clinical pharmacokinetics of oxaliplatin: a critical review.
    Graham MA, Lockwood GF, Greenslade D, Brienza S, Bayssas M, Gamelin E.
    Clin Cancer Res; 2000 Apr 15; 6(4):1205-18. PubMed ID: 10778943
    [Abstract] [Full Text] [Related]

  • 15. Clinical pharmacokinetics of carboplatin.
    Oguri S, Sakakibara T, Mase H, Shimizu T, Ishikawa K, Kimura K, Smyth RD.
    J Clin Pharmacol; 1988 Mar 15; 28(3):208-15. PubMed ID: 3283185
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of intravenously injected [3H]tetrachloro(D,L-trans)1,2-diaminocyclohexane platinum (IV) (tetraplatin) in mice.
    Kido Y, Khokhar AR, Siddik ZH.
    Drug Metab Dispos; 1992 Mar 15; 20(5):673-8. PubMed ID: 1358571
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics and pharmacodynamics of lobaplatin (D-19466) in patients with advanced solid tumors, including patients with impaired renal of liver function.
    Welink J, Boven E, Vermorken JB, Gall HE, van der Vijgh WJ.
    Clin Cancer Res; 1999 Sep 15; 5(9):2349-58. PubMed ID: 10499604
    [Abstract] [Full Text] [Related]

  • 18. Oxaliplatin biotransformation and pharmacokinetics: a pilot study to determine the possible relationship to neurotoxicity.
    Shord SS, Bernard SA, Lindley C, Blodgett A, Mehta V, Churchel MA, Poole M, Pescatore SL, Luo FR, Chaney SG.
    Anticancer Res; 2002 Sep 15; 22(4):2301-9. PubMed ID: 12174918
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of oxaliplatin (NSC 266046) alone and in combination with paclitaxel in cancer patients.
    Liu J, Kraut E, Bender J, Brooks R, Balcerzak S, Grever M, Stanley H, D'Ambrosio S, Gibson-D'Ambrosio R, Chan KK.
    Cancer Chemother Pharmacol; 2002 May 15; 49(5):367-74. PubMed ID: 11976830
    [Abstract] [Full Text] [Related]

  • 20. The disposition of carboplatin in ovarian cancer patients.
    Gaver RC, Colombo N, Green MD, George AM, Deeb G, Morris AD, Canetta RM, Speyer JL, Farmen RH, Muggia FM.
    Cancer Chemother Pharmacol; 1988 May 15; 22(3):263-70. PubMed ID: 3044634
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.